Raymond James analyst Michael Rose downgrades Atlantic Capital (NASDAQ:ACBI) from Outperform to Market Perform.
Wells Fargo Downgrades Zimmer Biomet Holdings to Underweight, Lowers Price Target to $124
Wells Fargo analyst Larry Biegelsen downgrades Zimmer Biomet Holdings (NYSE:ZBH) from Overweight to Underweight and lowers the price target from $170 to $124.